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Abstract
Maillard reacted peptides (MRPs) were synthesized by conjugating a peptide fraction (1000–5000 Da) puriﬁed from soy protein
hydrolyzate with galacturonic acid, glucosamine, xylose, fructose, or glucose. The effect of MRPs was investigated on human
salt taste and on the chorda tympani (CT) taste nerve responses to NaCl in Sprague–Dawley rats, wild-type, and transient
receptor potential vanilloid 1 (TRPV1) knockout mice. MRPs produced a biphasic effect on human salt taste perception and on
the CT responses in rats and wild-type mice in the presence of NaCl + benzamil (Bz, a blocker of epithelial Na
+ channels),
enhancing the NaCl response at low concentrations and suppressing it at high concentrations. The effectiveness of MRPs as
salt taste enhancers varied with the conjugated sugar moiety: galacturonic acid = glucosamine > xylose > fructose > glucose.
TheconcentrationsatwhichMRPsenhancedhumansalttasteweresigniﬁcantlylowerthantheconcentrationsofMRPsthatproduced
increase in the NaCl CTresponse. Elevated temperature, resiniferatoxin, capsaicin, and ethanol produced additive effects on the NaCl
CT responses in the presence of MRPs. Elevated temperature and ethanol also enhanced human salt taste perception.
N-(3-methoxyphenyl)-4-chlorocinnamid (a blocker of TRPV1t) inhibited the Bz-insensitive NaCl CT responses in the absence
and presence of MRPs. TRPV1 knockout mice demonstrated no Bz-insensitive NaCl CTresponse in the absence or presence of
MRPs. The results suggest that MRPs modulate human salt taste and the NaCl + Bz CTresponses by interacting with TRPV1t.
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Introduction
During the aging and/or cooking process, a reaction called
the ‘‘Maillard reaction’’ occurs between reducing carbohy-
drate and amino acids (Maillard 1912; Hodge 1953). A Mail-
lard reaction between D-glucose and D-alanine gives rise
to N-(1-carboxyethyl) 6-hydroxymethyl-pyridinium-3-ol, a
compound that has no taste by itself. However, it signiﬁ-
cantly enhanced sweet, salty, and umami taste in humans
(Soldo et al. 2003). It was also reported that Maillard pep-
tides (1000–5000 Da) generated during the aging of soy pesto
and soy sauce affected not only basic taste qualities but also
enhanced ‘‘kokumi,’’ a sensation of mouthfulness and con-
tinuity (Ogasawara et al. 2006a, 2006b, 2006c). In our pre-
liminary studies, Maillard peptides, depending upon their
concentration, enhanced or suppressed salt taste in human
psychophysical evaluation (Rhyu et al. 2006; Katsumata
et al. 2007). In this paper, we describe the puriﬁcation of
a 1000–5000 Da peptide fraction obtained from the enzy-
matic hydrolysis of soy protein that has no effect on human
salt taste by itself. However, when the Maillard reaction is
carried out between the peptide and different sugar moieties
which is glucose (Glc), xylose (Xyl), fructose (Fru), N-
glucosamine (GlcNH2), and galacturonic acid (GalA); the
above Maillard reacted peptides (MRPs) produce a biphasic
effect on human salt taste. We hypothesize that MRPs mod-
ulate salt taste by interacting with one or more salt taste re-
ceptors in taste receptor cells. To test if MRPs interact with
the amiloride-sensitive and/or amiloride-insensitive salt taste
receptors, we monitored chorda tympani (CT) taste nerve
responses to NaCl in Sprague–Dawley rats and in transient
receptor potential vanilloid 1 (TRPV1) knockout mice and
their wild-type control mice.
In mammals, 2 salt taste receptors have been characterized
so far: one that is Na
+ speciﬁc and asecond that does not dis-
criminate among Na
+,K
+, and NH4
+ (Stewart et al. 1997;
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receptorin the fungiform taste receptorcells is the amiloride-
and benzamil (Bz)-sensitive epithelial Na
+ channel and is the
predominant salt taste transducer in rats, many mice species
andhamsters(DeSimoneandLyall2006,2008).The nonspe-
ciﬁc salt taste receptor is amiloride and Bz insensitive and is
the predominant transducer of salt taste in some mammalian
species, including humans (Ossebaard and Smith 1995;
Feldman et al. 2003; Dewis et al. 2006; Katsumata et al.
2007). It is a constitutively active, nonselective cation chan-
nel (Lyall et al. 2004, 2005a, 2005b, 2005c, 2007) that dem-
onstrates many similarities with the cloned pain receptor
(TRPV1) (Caterina et al. 1997, 2000; Cortright et al.
2007). This candidate salt taste receptor is designated as
TRPV1t (Simon and De Araujo 2005). However, additional
amiloride-insensitive salt transduction mechanisms are pres-
entintastereceptorﬁeldsotherthantheanteriortongue(Lin
et al. 1999; Ruiz et al. 2006; Treesukosol et al. 2007).
Both the amiloride-sensitive and amiloride-insensitive
taste receptors are subject to acute modulation by effectors
commonly present in food and beverages. Changes in pH
(Lyall et al. 2002), osmolarity (Lyall et al. 1999), Ca
2+
(DeSimone and Lyall 2008), and temperature (DeSimone
and Lyall 2008) modulate the amiloride-sensitive CT re-
sponses to NaCl. On the other hand, vanilloids (resinifera-
toxin [RTX] and capsaicin [CAP]), ethanol, nicotine,
temperature, and external pH modulate the amiloride-
insensitive NaCl CT response (Lyall et al. 2004, 2005a,
2005b, 2005c, 2007). Thus, in principle, any one of the above
effectors should have both salt taste enhancer and/or
suppressor properties in both humans and in animal models.
Because the amiloride-insensitive salt taste receptors are the
predominant transducers of salt taste in humans (Ossebaard
and Smith 1995; Feldman et al. 2003), it is more useful to
consider TRPV1t modulators as perspective salt taste modi-
ﬁers in humans. Consistent with this hypothesis, several
studies suggest that TRPV1t modiﬁers, such as ethanol, el-
evated temperature (Hahn and Gunther 1932; Shizuyuki
1993; Martin and Pangborn 2006), N-geranyl cyclopropyl-
carboxamide (Dewis et al. 2006), naturally occurring Mail-
lardpeptides(Rhyuetal.2006),andMRPs(Katsumataetal.
2007) modulate human salt taste. An ideal human salt taste
enhancer or suppressor should be 1) tasteless, 2) odorless, 3)
nonpungent, 4) stable at high temperatures, 5) effective at
relativelylowconcentrations,6)acutelyeffectiveinmodulat-
ing the salt taste receptor, 7) completely reversible upon
washout, and 8) additive with other TRPV1t modulators
on the salt taste response.
The results presented in this paper showthat MRPs atcon-
centrations <0.01% enhanced and >0.01% suppressed hu-
man salt taste. MRPs also produced biphasic effects on
the amiloride- and Bz-insensitive NaCl CT responses in con-
trol rats and wild-type TRPV1 mice. At concentrations
<0.5%, MRPs enhanced and >0.5% inhibited the CT re-
sponse. In both human salt taste evaluation and NaCl CT
responses, the potency of MRPs conjugated with different
sugar moieties was GalA ‡ GlcNH2 > Xyl > Fru > Glc.
In TRPV1 knockout mice, that lack the Bz-insensitive com-
ponent of the NaCl CT response, no effect of MRPs was ob-
served on the CT response to NaCl + Bz. These studies
suggest that a relationship exists between the MRPs-induced
increase or decrease in human salt taste and TRPV1t. Some
of the data have been published earlier as abstracts (Rhyu
et al. 2006; Katsumata et al. 2007).
Materials and methods
Allchemicals wereofreagent gradeorHPLCgradeandwere
purchased from Sigma, St Louis, MO; Wako Pure Chemical
Industries Ltd, Tokyo, Japan; or Nacalai Tesque Inc.,
Tokyo, Japan. Alcalase 2.4 L (Bacillus licheniformis) was
purchased from Novozyme, Tokyo, Japan.Soybean protein,
containing 90% protein, was purchased from Fuji Oil Co.,
Ltd, Tokyo, Japan.
Preparation of the 1000–5000 Da peptide fraction from
soy protein
Fifteen grams of puriﬁed soy protein was dissolved in dis-
tilled water to obtain 15% (w/v) protein slurry and hydro-
lyzed at 50  C at pH 8.0 for 24 h in the presence of 0.14
gm of the protease, alcalase. The hydrolyzate was incubated
at 95  C for 10 min to inactivate the protease and any result-
ing precipitate was removed by centrifugation at 5000 · g for
20 min at 4  C. The supernatant was ultraﬁltered through
1000 and 5000 Da cut-off membranes (Millipore Co.,
Milford, MA). The resulting 1000–5000 Da protein fraction
was freeze dried and stored at –18  C until used.
One-fourth of agram of Xyl and 1 gm of the 1000- to 5000-
Da protein fraction were dissolved in distilled water to
obtain a 24% solution (w/v). Similarly, each of the sugar
moieties GalA, GlcNH2, Glc, and Fru was used at a peptide
tosugarmoietyratioof4:1.Thismixture washeatedto95 C
for 4.5 h and then fractionated with 1000 and 5000 Da mem-
branes. The 1000–5000 Da fractions (MRPs) were freeze
dried and stored at –18  C until used (Ogasawara et al.
2006a).
CT taste nerve recordings
Animals were housed in the Virginia Commonwealth
University animal facility in accordance with institutional
guidelines. All animal protocols were approved by the Insti-
tutional Animal Care and Use Committee (IACUC) of Vir-
ginia Commonwealth University. Female Sprague–Dawley
rats (150–200 gm) were anesthetized by intraperitoneal injec-
tion of pentobarbital (60 mg/kg), and supplemental pento-
barbital (20 mg/kg) was administered as necessary to
maintain surgical anesthesia. The animal’s corneal reﬂex
and toe-pinch reﬂex were used to monitor the depth of sur-
gical anesthesia. Body temperatures were maintained at
37
o C with a Deltaphase Isothermal PAD (Model 39 DP;
666 T. Katsumata et al.Braintree Scientiﬁc Inc., Braintree, MA). The left CT nerve
was exposed laterally as it exited the tympanic bulla and
placed onto a 32-G platinum/iridium wire electrode. The
CT responses were recorded under zero lingual current
clamp and analyzed as described previously (Lyall et al.
2005a, 2005b, 2005c, 2007).
CTresponseswerealsomonitoredinwild-type (C57BL/6J)
and homozygous TRPV1 knockout mice (B6. 129S4-
Trpv1
tmijul; The Jackson Laboratory, Bar Harbor, ME).
Mice (30–40 gm) were anesthetized by intraperitoneal injec-
tion of pentobarbital (30 mg/kg), and supplemental pento-
barbital (10 mg/kg) was administered as necessary to
maintain surgical anesthesia. The rest of the procedure
was the same as described above for rats (Lyall et al.
2004, 2005a, 2005b, 2005c, 2007). At the end of each exper-
iment, animals were humanely killed by an intraperitoneal
overdose of pentobarbital (c.a., 195 mg/kg body weight
for rats and 150 mg/kg weight for mice).
The composition of rinse and NaCl stimulating solu-
tions is shown in Table 1. The anterior lingual surface
was stimulated with the rinse solution and salt solutions with
or without MRPs and the nonreacted peptide (0–1%). The
salt solutions containing MRPs had a pH of 6.4. In some
experiments, Bz or N-(3-methoxyphenyl)-4-chlorocinnamide
(SB-366791; SB) was added to the rinse and/or salt solutions
to block Na
+ entry into taste receptor cells via the apical
epithelial Na
+ channels and/or TRPV1t (Gunthorpe et al.
2004; Lyall et al. 2004, 2005b, 2005c, 2007). We also mon-
itored the CT response to N + Bz containing a ﬁxed concen-
tration of Gal-MRP as a function of variation in pH between
4.1 and 9.1 (Table 1). In each case, the rinse solution was
adjusted to the same pH as the stimulating salt solution.
This was done to eliminate the contribution of changes
in pH to the NaCl CT response (Lyall et al. 2002). CT re-
sponses were also recorded in the presence of TRPV1 mod-
ulators: RTX, CAP, ethanol, or elevated temperature. In
some experiments, we tested the effect of MRPs on the
CT response to monosodium glutamate (MSG) and
MSG + inosine 5#-monophosphate (IMP) (Table 1). IMP
is a speciﬁc modulator of umami taste (Yamaguchi
1991). CT responses to MSG were monitored in the pres-
ence of Bz and SB (Table 1). This was done to eliminate the
contribution of Na
+ ﬂux via epithelial Na
+ channels and
TRPV1t to the CT response to glutamate (Lyall et al.
2004). Typically, stimulus solutions remained on the tongue
for 1 min. Control stimuli consisting of 0.3 M NH4Cl and
0.3 M NaCl applied at the beginning and at the end of ex-
periment were used to assess preparation stability. The fol-
lowing stimulus series were used in the CT experiments:
Series 1
R/0:3M NH4Cl/R/0:3 M NaCl/R/N
/R/ðN+BzÞ/R/ðN+Bz+MRPÞ/R
The R / (N + Bz + MRP) / R step was repeated for each
concentration of MRP between 0.1% and 1%. At the end of
the MRP concentration series, the control stimuli were again
applied (R / 0.3 M NH4Cl / R / 0.3 M NaCl / R). In
some experiments, additional steps in the stimulus series
protocol involved: (N + Bz), (N + Bz + RTX), (N + Bz +
CAP), (N + Bz + MRPs), (N + Bz + MRPs + RTX), (N +
Bz + MRP + CAP), and (N + Bz + ethanol).
Table 1 Stimuli used for CT experiments
Rinse M Salt stimuli M
R 0.01 KCl N 0.01 KCl + 0.1 NaCl
R 0.01 KCl N + Bz 0.01 KCl + 0.1 NaCl + 5 · 10
 6 Bz
R 0.01 KCl N + Bz + MRPs 0.01 KCl + 0.1 NaCl + 5 · 10
 6 Bz + MRPs (0–1%)
R 0.01 KCl N + Bz + MRPs + TRPV1t modulators
a 0.01 KCl + 0.1 NaCl + 5 · 10
 6 Bz + MRPs (0–1%) + TRPV1t modulators
a
R 0.01 KCl MSG + Bz + SB 0.01 KCl + 0.1 MSG + 5 · 10
 6 Bz + 1 · 10
 6 Bz SB
R 0.01 KCl MSG + Bz + SB + IMP 0.01 KCl + 0.1 MSG + 5 · 10
 6 Bz + 1 · 10
 6 Bz SB + 1 · 10
 3 IMP
(R)pH
b 0.01 KCl + 0.01 HEPES/Tris (N + Bz + MRPs)pH
b 0.01 KCl + 0.01 HEPES/Tris + 0.1 NaCl + 5 · 10
 6 Bz + MRPs (0–1%)
R 0.01 KCl Control solution 1 0.3 NH4Cl
R 0.01 KCl Control solution 2 0.3 NaCl
MRPs: GalA-MRP; GlcNH2-MRP; Xyl-MRP; Fru-MRP; Glc-MRP. The concentration of MRPs is in percent. In some experiments, we also tested the effect of the
unreacted soy protein fraction.
aTRPV1 modulators: RTX (0.25 · 10
 6 M); CAP (20 · 10
 6 M); ethanol (20% or 40%); SB (N-(3-methoxyphenyl)-4-chlorocinnamide; SB-366791), a speciﬁc
blocker of TRPV1t. In some experiments, SB was used at 5 · 10
 6 M; Bz, a speciﬁc blocker of the epithelial Na
+ channel.
bHEPES (4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid) or Tris (tris(hydroxymethyl)aminomethane) were used to buffer the pH of (R)pH and (N + Bz +
MRPs)pH between pH 4.1 and 9.1.
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R/0:3MNH 4Cl/R/0:3 M NaCl/R
/ðR+Bz+SBÞ/ðN+Bz +SBÞ/ðR+Bz+SBÞ
/ðN + Bz + SB + MRPÞ/R/0:3M NH4Cl/R
/0:3M NaCl/R
Series 3
R/ 0:3MN H 4Cl/R/0:3 M NaCl/R
/ðN + BzÞ/R/ðN + Bz + MRPÞ/R
/ðN + BzÞ30:2 /R/ðN + Bz + MRPÞ30:2 /R
The R /(N+ Bz) /R/(N +Bz +MRP)/R stepwas
repeated for (N + Bz) and (N + Bz + MRP) maintained at
38.6  C and 41.9  C. At the end of the temperature series, the
control stimuli were again applied (R / 0.3 M NH4Cl /
R / 0.3 M NaCl / R). In these experiments, the lingual
surface was superfused with salt solutions maintained at
30.2  C, 38.6  C, and 41.9  C while rinse (R) was maintained
at room temperature (23  C).
In CT experiments, both transient (phasic) and tonic
(steady state) parts of the NaCl CT responses were quanti-
ﬁed. We also quantiﬁed the transient (phasic) response to the
applicationofrinse(R)toatonguealreadysuperfusedwithR.
To quantify the phasic part of the CT response, the height of
the stimulus-induced maximum CT response relative to
baseline response was divided by the mean steady state
(tonic) response to 0.3 M NH4Cl. To quantify the tonic part
of a response, the area under the response versus time curve
was taken over the ﬁnal 30 s of the response. To normalize
this result, this area was divided by the area under the 0.3 M
NH4Cl response curveovertheﬁnal30softhetonic response
period. The normalized data were reported as mean ± stan-
dard error of the mean of the number of animals. Student’s
t-test was employed to analyze the differences between sets
of data. Because we are comparing the normalized CT
responses before and after TRPV1t modulators in the same
CT preparation, paired t-test was used to evaluate statistical
signiﬁcance.
For clarity, the points on the graphs of the mean normal-
ized phasic and tonic responses versus the logarithm of the
GalA-MRP concentration were connected respectively by
smooth curves. The curves were generated using a ﬁtting
function that models the characteristic biphasic property
of the peptide agonists of TRPV1. The biphasic property
has been observed with every agonist of TRPV1t thus far ex-
amined (Lyall et al. 2004, 2005b, 2005c, 2007). The ﬁtting
function used was
R=
r+bhðxÞ
1+hðxÞ+jðxÞ
ð1Þ
where
hðxÞ=10 nðx–aÞ ð2Þ
and
jðxÞ=10 nðx–aÞ+mðx–dÞ ð3Þ
Here, R is the response, x is the logarithm of the GalA-MRP
concentration expressed in percent and a, b, d, m, n, and r are
parameters chosen by least squares criteria.
Human salt sensory evaluation
A total of 8–14 healthy volunteers (24–44 years old) partic-
ipated in salt sensory evaluation experiments. All volunteers
were employees of the Kyowa Hakko Food Specialties Co.,
Ltd, Ibaraki, Japan. The volunteers had training in taste sen-
sory evaluation and extensive experience with psychophysi-
cal studies. Freshly distilled water was used to prepare the
test solutions for taste evaluation. One-ounce (29.6 ml) sam-
ples were presented in opaque disposable plastic cups. All
tests were conducted in individual sensory test booths.
Two independent methods were used to assess the effect of
MRPs on human salt taste perception. In the ﬁrst case, we
used the constant stimuli method (Masuyama and Miura
1963; Johansson and Drake 1973; Kobayashi et al. 1974)
to assess the effect of MRPs on human salt taste perception.
Two experimental series, below called enhancing and sup-
pressing, were performed with the test MRP concentration
of 0.0025%, 0.005%, 0.01%, 0.025%, and 0.1% in 0.08 M
NaCl. In the ﬁrst case, 5 equidistant concentrations ranging
from 0.078–0.086 M NaCl were used; and in the second case,
the 5 equidistant NaCl concentrations ranging from 0.074–
0.082 M were used (Table 2). In each session, the subjects
were presented with 5 pairs of samples containing test
MRP andpureNaClsolution.The subject’s taskwas to taste
each pair and to indicate which of the 2 samples was saltier.
Each pair consisted of one sample of MRP + NaCl solution
and one sample of solution that had higher or lower concen-
tration of NaCl.
The data were analyzed using Probit analysis (methods
of maximum likelihood) (Finney 1980) to obtain an esti-
mate of the median effective dose that produced a change
in salt taste intensity. The number of times (expressed as per-
cent) an individual identiﬁed the saltier sample correctly
or incorrectly were designated as PC and PI, respectively.
The values of PC and PI were plotted as a function of the
standard NaCl solution concentrations given above. The
x-intercept of the ﬁtted lines was calculated for all PC
(P#C)a n dPI (P#I) values. The median effective dose was
calculated using the ﬁtting parameters P#C, P#I and values
of parameters Y, w,a n dy from Probits analysis (Harris and
Lieberman 1983). Y and y were designated as Probits and
workingprobits from standardtables (Finney 1980) byusing
parameters P#C and P#I.
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The additive effects between GalA-MRP and ethanol were
also evaluated by the above method. This experiment was
performed with 0.01% GalA-MRP and 4% ethanol in 0.08 M
NaCl solution. The additive effects between GalA-MRP
and elevated temperature were also evaluated by the above
method. In this experiment, the temperature of pure NaCl
standard solution and the test solution containing 0.01%
GalA-MRP were maintained at 30  Co r4 5 C during salt
taste evaluation. Equations (1–3) were also used to ﬁt human
sensory data.
The effectofMRPsonthesalttastewasalsoassessedusing
a quantitative descriptive analysis method and a 7-point in-
tensity scale (1 = none and 7 = very strong) (Ogasawara et al.
2006a) in a 0.3% model vegetable soup (Table 2). The soup
without MRPs was presented as a control and given an in-
tensity of 4 on a 7-point intensity scale. This experiment was
performed with the test MRPs concentrations of 0.00001%,
0.00002%, 0.00005%, 0.0001%, 0.0002%, 0.001%, 0.005%,
and 0.01% in 0.3% vegetable soup. The ﬁnal salinity of
the test solution was adjusted to 0.1 M NaCl. Volunteers
tasted the soup without and with MRPs and indicated
how strong the salt taste perception was of the soup contain-
ing MRPs relative to the soup without MRPs. In some
experiments, the quantitative descriptive analysis method
was used to evaluate the effect of GalA-MRP on human salt
perception in 0.15 M NaCl solution containing 50 · 10
–6 M
amiloride, a blocker of epithelial Na
+ channels. Two-sided
paired t-test was used to evaluate statistical signiﬁcance.
All statistical signiﬁcant values were Bonferroni adjusted.
Results
Effect of GalA-MRP on the Bz-insensitive NaCl CT
response in rats
GalA-MRP dissolved in the rinse solution (R; Table 1) eli-
cited only transient CT responses that were concentration
independent and were indistinguishable from the mechanical
rinse artifact (Figure 1A). This suggests that within the range
ofconcentrations(0.1–1%)usedinthisstudy, GalA-MRP by
itself does not elicit a CT response. Adding increasing con-
centrations of GalA-MRP to stimulating solutions contain-
ing N + Bz (Table 1) initially produced an increase in both
phasic and tonic NaCl CT responses between 0.1% and
0.25% (Figure 1B). Above 0.5% GalA-MRP, the magnitudes
of the phasic and tonic CT responses were less than their re-
spective maximum values. At 1% GalA-MRP, the tonic CT
response decreased below the value of N + Bz alone (Figure
1B). The normalized mean results from 3 such experiments
are summarized in Figure 1C,D. GalA-MRP produced a bi-
phasic dose-response relationship for both phasic (Figure 1C)
and tonic (Figure 1D) NaCl CT responses. The maximum
increase in the mean normalized phasic and tonic CT re-
sponses occurred at approximately the same GalA-MRP
concentration (0.31% and 0.27% GalA-MRP, respectively) as
estimated from the ﬁtted curves. At a concentration of 0.27%,
Table 2 Stimuli used for human sensory evaluation
Wash Control Salt stimuli
H2O 0.074 M NaCl, 0.076 M NaCl, 0.078 M NaCl, 0.08 M NaCl,
0.082 M NaCl, 0.084 M NaCl, and 0.086 M NaCl
0.08 M NaCl + MRPs (0.0025–0.1%)
H2O 0.078 M NaCl, 0.080 M NaCl, 0.082 M NaCl, 0.084 M NaCl,
and 0.086 M NaCl
0.08 M NaCl + 4% ethanol + MRPs (0.02%)
H2O 0.3% Vegetable soup + 0.1 M NaCl 0.3% Vegetable soup + 0.1 M NaCl + MRPs (0.00001–0.02%)
H2O 0.15 M NaCl + 50 · 10
 6 M amiloride 0.15 M NaCl + 50 · 10
 6 M amiloride + GalA-MRP (0.002–0.1%)
Vegetable soup = 41.52% sugar, 37.3% MSG, 13.84% onion powder, 4.21% WMP (IMP and guanosine 5’-monophosphate), 2.41% Na citrate, 0.6% garlic
powder, and 0.12% celery powder. MRPs: GalA-MRP; GlcNH2-MRP; Xyl-MRP; Fru-MRP. The concentration of MRPs is in percent.
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NaCl tonic CT response by 101% relative to N + Bz. At
0.75% GalA-MRP, the tonic CT response was not statisti-
cally different from its value in N + Bz alone (P > 0.05). At
1%, the tonic CT response was inhibited by 54.8% relative
to N + Bz (Figure 1D). The magnitude of the phasic CT
response at 0.75% and 1% GalA-MRP was not different
from its value in N + Bz alone (Figure 1C). These results
demonstrate that both the phasic and tonic components of
the Bz-insensitive NaCl CT response produce similar GalA-
MRP concentration-response relations.
Effect of SB on the NaCl CT response in the absence and
presence of GalA-MRP
Rat NaCl CT responses were monitored under control con-
dition and in the presence of Bz alone, SB alone, or Bz + SB
relative to the rinse (R; Table 1). Bz decreased the mean nor-
malized phasicNaClCT response (Figure2A) by46.8% (N+
Bz). In the presence of Bz + SB, the mean normalized phasic
CT response (N+ Bz + SB) was furtherdecreased to 60.4% of
control,avaluethatwasslightlybigger thantherinse artifact
(R; P < 0.002). Bz decreased the mean normalized tonic
NaCl CT response by 68.6% (N + Bz); and in the presence
of Bz + SB, it further decreased to 98.0% of control (N + Bz +
SB), a value that was not statistically different from baseline
(Figure 2B; P>0.05 with respect to zero). These resultsshow
that in the presence of Bz, SB blocks both phasic and tonic
NaCl CT responses.
In the presence of SB (1 · 10
–6 M), GalA-MRP (0.25%)
produced no signiﬁcant increase in the normalized mean
tonic CT response (N + Bz + SB + GalA-MRP) above base-
line (Figure 2B). GalA-MRP elicited no tonic CT response
above baseline whether Bz + SB were added in the salt stim-
ulus alone (Figure 2B; open bar) or when Bz + SB were pres-
ent in both rinse (R + Bz + SB) and the salt stimulus (Figure
2B;hatched bar).Inthepresence ofSB,themeannormalized
phasic CT response in the presence of 0.25% GalA-MRP
(N+ Bz + SB+ GalA-MRP) was slightly bigger than its value
in (N + Bz) (P < 0.05). There was no difference in the mag-
nitude of the phasic response in the presence of GalA-MRP
whether Bz + SB were added to the salt stimulus alone or to
both R and the salt stimulus (Figure 2A; hatched bar). The
results show that SB inhibits the effect of GalA-MRP on
both phasic and tonic Bz-insensitive NaCl CT responses.
These results further suggest that SB inhibits the constitu-
tively active TRPV1t in fungiform taste receptor cells and
its subsequent activation by GalA-MRP.
To test if GalA-MRP speciﬁcally affects TRPV1t, we also
monitored the effect of GalA-MRP on the Bz-sensitive NaCl
CT responses in thepresence SBalone. Inthe presence ofSB,
the NaCl CT response is derived only from the Na
+ inﬂux
into taste receptor cells through apical epithelial Na
+ chan-
nels. In the presence of 5 · 10
–6 M SB, GalA-MRP (0.1–1%)
had no effect on the tonic (Figure 2C) and phasic (data not
shown) NaCl CT response relative to N + SB alone. These
results suggest that GalA-MRP does not modulate the activ-
ity of epithelial Na
+ channels in the apical membrane of fun-
giform taste receptor cells.
External pH, temperature, RTX, CAP, and ethanol modulate
the effects of GalA-MRP on the NaCl CT response
At a ﬁxed GalA-MRP concentration (0.25%), both phasic
(Figure 3A; open circles) and tonic (Figure 3A; ﬁlled circles),
Figure 1 Effect of GalA-MRP on the Bz-insensitive NaCl CT response.
(A) Shows a representative trace of a CT response obtained while the rat
tongue was stimulated with the rinse (R) alone and then with R + GalA-MRP
at 0.5% and 1.0% maintained at 23  C (Table 1). The arrows show the time
period when the tongue was superfused with R or R + GalA-MRP. (B) Shows
a representative trace of a CT response obtained while the rat tongue was
ﬁrst stimulated with R and then with N + Bz solutions containing GalA-MRP
(0–1%) maintained at 23  C (Table 1) using Stimulus Series 1 protocol (see
Material and methods). The mean   standard error of the mean values of
the normalized phasic (C) and tonic (D) CT responses from 3 animals are
plotted as a function of log[GalA-MRP] concentration. At 0.1%, 0.25%, 0.5%,
0.75%, and 1% GalA-MRP, the paired P values for the phasic response were
0.047, 0.005, 0.001, 0.825, and 0.52, respectively, and for the tonic
response were 0.0001, 0.0001, 0.0001, 0.13, and 0.0011, respectively, with
reference to 0 GalA-MRP.
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relationship with changes in external pH between 4.1 and 9.1
(Supplement Figure 1A). Similarly, nicotine, a TRPV1t ag-
onist also enhanced the Bz-insensitive NaCl CT responses at
all pHs between 4 and 9 relative to N + Bz alone (Lyall et al.
2007). The maximum increase in the phasic CT response was
observed around pH 7, whereas the tonic CT response
showed maximum activity between pH 6 and 7. In 4 animals,
the mean normalized tonic CT responses in the presence of
GalA-MRP at pH 4.1 and pH 9.1 were signiﬁcantly greater
than the N + Bz tonic CT response (P < 0.05 and P < 0.002,
respectively). These results suggest that GalA-MRP enhan-
ces the N + Bz CT response at all pHs between 4.1 and 9.1. In
our previous studies, all TRPV1t modulators tested (RTX,
CAP, ethanol, nicotine, and cetylpyridinium chloride) pro-
duced a maximum increase in the Bz-insensitive tonic NaCl
CT responses between pH 6 and pH 7 (Lyall et al. 2004,
2005a, 2005b, 2005c, 2007). Accordingly, in this study, all
salt solutions containing MRPs used in CT experiments
and in human psychophysical studies had a pH of 6.4.
Increasing the temperature from 23.2  C to 30.2  C,
38.6  C, and 41.9  C (Table 1) increased the magnitude of
the phasic and tonic Bz-insensitive NaCl CT responses
(N + Bz) relative to 23.2  C (Figure 3B and Supplement
Figure 1B). At all temperatures studied, GalA-MRP pro-
ducedasigniﬁcantlygreaterincrease(P<0.0001)inthetonic
CT response (N + Bz + GalA-MRP) relative to (N + Bz)
(Figure 3B). These results suggest that elevated temperature
andGalA-MRPproduce additive effects ontheBz-insensitive
NaCl CT response. Because our results demonstrate a strong
relation between phasic and tonic NaCl CT responses under
a variety of conditions, in the rest of the paper results only from
the tonic Bz-insensitive NaCl CT response will be reported.
The Bz-insensitive NaCl CT response was enhanced in the
presence of RTX (0.25 · 10
–6 M) (Figure 3C). In mixtures
containing RTX + GalA-MRP (0.25%), the tonic CT re-
sponse was enhanced relative to NaCl solutions containing
RTX alone or GalA-MRP alone (Figure 3C). Similarly,
in the presence of a subthreshold concentration of CAP
(20 · 10
–6 M), which by itself did not give a signiﬁcant in-
crease in the tonic CT response relative to N + Bz, GalA-
MRP also produced a signiﬁcantly greater response relative
to its value in the presence of CAP alone and GalA-MRP
alone (Figure 3C). It is important to note that the effect
of CAP + GalA-MRP and RTX + GalA-MRP was superad-
ditive, that is, the combined response was greater than the
sum of the individual CT responses to CAP, RTX, and
GalA-MRP.
Ethanol, a modulator of TRPV1t (Lyall et al. 2005a,
2005b), at 20% and 40% enhanced the N + Bz tonic CT
response in a dose-dependent manner (Figure 3D). In mix-
tures containing ethanol and GalA-MRP (0.25%), the CT
responses were enhanced relative to their respective values
in ethanol alone (Figure 3D). In the mixture, tonic CT re-
sponses to ethanol and GalA-MRP were additive.
Effect of MRPs conjugated with different sugar moieties on
the Bz-insensitive NaCl CT response
To test if the effect of MRPs on the Bz-insensitive NaCl CT
response is dependent upon the conjugated sugar moiety, the
1000–5000 Da peptide was conjugated with GalA, GlcNH2,
Figure 2 Effect of GalA-MRP on the NaCl CTresponses in the presence of
SB. CT responses were monitored while the rat tongue was stimulated with
R, N, N + Bz, N + Bz + SB and N + Bz + SB + 0.25% GalA-MRP (Table 1) using
Stimulus Series 2 protocol (see Materials and methods). The mean  
standard error of the mean (SEM) values of the normalized phasic (A) and
tonic (B) NaCl CT responses from 3 animals are shown. The hatched bars
show the CTresponse when Bz + SB were present in both rinse and the salt
stimulus. In (A), the P values for phasic response for N + Bz, N + Bz + SB, N +
Bz + SB + GalA-MRP with respect to R were 0.0004, 0.0042, and 0.0011,
respectively. The P value for N + Bz + SB + GalA-MRP with respect to N + Bz +
SB was 0.035. In (B), the values of the tonic response for N + Bz + SB, N +
Bz + SB + GalA-MRP were not different from zero (P > 0.05). (C) Shows the
mean   SEM values of the normalized tonic NaCl CT response in 3 animals
as a function of GalA-MRP concentration in the presence of N + SB (Table 1).
Relationship Between Human Salt Taste and TRPV1t 671Glc, Fru, or Xyl. We obtained the dose-response relation be-
tween MRP concentration and the magnitude of the Bz-
insensitive NaCl CT response in rats for each of the MRPs.
As shown in Figure 4 and Table 3, both the maximum in-
crease in the Bz-insensitive NaCl tonic CT response and
the MRP concentration at which the maximum increase
in the tonic CT response is observed varied with the sugar
moiety. The effectiveness of various MRPs conjugated with
different sugar moieties to modulate the Bz-insensitive NaCl
tonic CT response was GlcNH2 ‡ GalA > Xyl > Fru > Glc
(Table 3). The most effective modulators of the Bz-insensi-
tive NaCl response were GalA-MRP and GlcNH2-MRP. In
contrast toMRPs, the unreacted peptide hadno effecton the
tonic (Figure 5; ﬁlled circle) and phasic (data not shown) CT
response in the presence of N + Bz.
CT responses in the wild-type and TRPV1 knockout mice
In order to conﬁrm that GalA-MRP produces its effect by
interacting with TRPV1t, NaCl CT recordings were made
in both wild-type and TRPV1 knockout mice. Similar to
the case in rats (Figure 1), in wild-type mice, the phasic
and tonic Bz-insensitive NaCl CT responses demonstrated
a biphasic response to increasing GalA-MRP concentrations
(Figure 5A). The maximum increase in the phasic and tonic
CT response was observed around 0.25% GalA-MRP. SB
(1 · 10
–6 M) inhibited the CT response to 0.25% GalA-MRP
to near baseline. However, in the TRPV1 knockout mice,
which lack the Bz-insensitive component of the NaCl CT re-
sponse, GalA-MRP between 0.1% and 1% did not increase
the tonic CT response to N + Bz above baseline (Figure 5B).
Similarly, the phasic CT response was not affected with in-
creasing GalA-MRP concentrations relative to N + Bz. The
mean phasic and tonic CT responses in 3 wild-type and 3
knockout mice are summarized in Figure 5C,D, respectively.
The results suggest that in mice in which TRPV1 is silenced,
GalA-MRP does not modulate CT responses in the pres-
ence of N + Bz. The results in TRPV1 knockout mice
are equivalent to the results obtained in rats and wild-type
mice in the presence of Bz + SB (Figure 2A,B).
Figure 3 Modulatory effect of external pH (pH0), elevated temperature, capsaicin (CAP), resiniferatoxin (RTX), and ethanol (ETH) on the Bz-insensitive NaCl
CTresponse. (A) Rat tongue was ﬁrst stimulated with R and then with N + Bz containing 0.25% GalA-MRP maintained at 23  C. Both R and N + Bz + GalA-
MRP solutions were adjusted to pHs between 4.1 and 9.1 (Table 1). The mean   standard error of the mean (SEM) values of the normalized phasic (open
circle) tonic (ﬁlled circles) CT response from 3 animals are plotted as a function of pH0. (B) Rat tongue was ﬁrst stimulated with R and then with N + Bz
solutions containing 0.25% GalA-MRP maintained at 23  C, 30.2  C, 38.6  C, and 41.9  C (Table 1) using Stimulus Series 3 protocol (see Materials and
methods). The normalized mean   SEM values of the tonic CTresponse from 3 animals are plotted as a function of temperature. *P < 0.0001. (C) Rat tongue
was ﬁrst stimulated with R and then with N + Bz, N + Bz + CAP (20 · 10
 6 M), N + Bz + RTX (0.25 · 10
 6 M), N + Bz + 0.25% GalA-MRP, N + Bz + CAP +
GalA-MRP, and N + Bz + RTX + GalA-MRP maintained at 23  C (Table 1). The mean   SEM values of the mean normalized tonic CTresponse from 3 animals
are plotted in the presence of above TRPV1t modulators. *P < 0.0001. (D) Rat tongue was ﬁrst stimulated with R and then with N + Bz, N + Bz + 20% ETH,
N + Bz + 40% ETH, N + Bz + 0.25% GalA-MRP, N + Bz + 20% ETH + GalA-MRP, and N + Bz + 40% ETH + GalA-MRP maintained at 23  C (Table 1). The mean
SEM values of the normalized tonic CT response from 3 animals are plotted in the absence and presence of above TRPV1t modulators. *P < 0.0001.
672 T. Katsumata et al.Effect of MRPs on the CT response to MSG
Xyl-MRP has been reported to modulate not only human
salt taste but also to affect umami taste (Ogasawara et al.
2006a). Accordingly, we tested the effect of MRPs on the
rat CT response to MSG and MSG + IMP (Table 1). Bz
and SB were added to eliminate the contribution of Na
+
to the CT response (Figure 2). Thus, in the presence of Bz +
SB the CT response to MSG is due to glutamate only. Con-
sistent with previous reports (Li et al. 2002; Damak et al.
2003), IMP enhanced the CT response relative to MSG alone
(Figure 6A). In 3 animals, IMP (1 · 10
–3 M) or Xyl-MRP
(2.5%) signiﬁcantly increased the mean normalized tonic
CT response to MSG + SB + Bz (Figure 6B; P < 0.001).
The effect of Xyl-MRP on the CT response to MSG + Bz +
SB was not observed at concentrations £1%, that is, at con-
centrations at which Xyl-MRP modulated the Bz-insensitive
NaCl CT responses (Figure 6A). However, in the presence
of IMP + Xyl-MRP the magnitude of the mean normalized
CT response to MSG + SB + Bz was less than additive rel-
ative to the CT response to IMP alone or Xyl-MRP alone
Figure 5 Effect of GalA-MRP on wild-type and TRPV1 knockout mice.
Mouse tongues were ﬁrst stimulated with R and then with N + Bz solutions
containing increasing concentrations of GalA-MRP maintained at 23  C
(Table 1) using Stimulus Series 1 protocol (see Materials and methods).
Representative traces of a Bz-insensitive NaCl CT response are shown for
a wild-type (WT) mouse (A) and a TRPV1 knockout (KO) mouse (B) as
a function of GalA-MRP concentration. The relation between normalized
mean   standard error of the mean phasic (C) and tonic (D) Bz-insensitive
NaCl CT response and log[GalA-MRP] concentration in 3 WT (open circle)
and 3 KO (ﬁlled circles) are also shown. In WT mice, at 0.1%, 0.25%, 0.5%,
and 0.75%, GalA-MRP the paired P values for the phasic response were
0.008, 0.003, 0.0013, and 0.016, respectively and for the tonic response
were 0.0006, 0.0006, 0.0001, and 0.012, respectively, with reference to
0 GalA-MRP. In KO mice, the phasic and tonic CT responses were not
signiﬁcantly different from their respective values in the absence of GalA-MRP.
Figure 4 Effect of MRPs conjugated with different sugar moieties on the
Bz-insensitive NaCl CTresponse. Rat CTresponses were measured while the
tongue was stimulated with R and then with N + Bz solutions containing
0–1% MRPs conjugated with glucosamine (GlcNH2), galacturonic acid
(GalA), xylose (Xyl), fructose (Fru), glucose (Glc), and the unreacted peptide
maintained at 23  C. The normalized mean   standard error of the mean
values of the tonic CT response from 3 animals are plotted as a function of
log[MRP] concentration. The normalized mean values of maximum CT
response and the MRP concentration that produces a maximum response
are summarized in Table 3.
Table 3 Maximum CT response to MRPs
MRPs CT Response
0.25% GalA-MRP 0.203
0.25% GlcNH2-MRP 0.223
0.50% Xyl-MRP 0.192
0.75% Fru-MRP 0.186
1.0% Glc-MRP 0.220
CTresponse = maximum value of the Bz-insensitive NaCl tonic CTresponse/
0.3 M NH4Cl. MRP concentration that produces maximum CTresponse was
calculated from Figure 4.
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GlcNH2-MRP did not modulate the CT response to MSG +
Bz + SB.
Effect of MRPs on human salt taste
We used an estimation of the median effective dose to assess
the effect of MRPs on the salt intensity of 0.08 M NaCl in
human psychophysical tests (Figure 7A). Between 0.0025%
and 0.01%, both GalA-MRP and Xyl-MRP (Figure 7A) in-
creased, and above 0.01% suppressed the salt taste intensity.
In the presence of 0.01% GalA-MRP and Xyl-MRP, the
median effective salt concentration was maximally enhanced
by 5.9% and 3.5%, respectively. In contrast, Fru-MRP
(Figure 7A; inverted ﬁlled triangle) showed a maximum
salt-enhancing effect (3.2%) at 0.1%. The data demonstrate
that in the presence of 0.01% and 0.1% GalA–MRP, the salt
intensity rating of 0.08 M NaCl solution was equivalent to
that of 0.0847 M NaCl and 0.0775 M NaCl, respectively.
Xyl-MRP showed a similar biphasic effect on NaCl intensity
but was slightly less effective than GalA-MRP. In contrast,
the NaCl intensity response curve was shifted to the right in
the presence of 0.08 M NaCl + Fru-MRP. In this case, the
maximum increase in the NaCl intensity was observed at
0.1% Fru-MRP. These results are consistent with the biphasic
effect of MRPs observed on the CT response to NaCl + Bz
(Figure 4). However, the increase in the human sensory
response of MRPs was observed at signiﬁcantly lower
Figure 6 Effect of MRPs on the CTresponse to MSG, IMP, and MSG + IMP.
(A) Rat tongue was ﬁrst stimulated with R and then with MSG solutions
containing Bz + SB (MSG + Bz + SB), IMP (MSG + Bz + SB + IMP), GalA-MRP
(MSG + Bz + SB + GalA-MRP), GlcNH2 (MSG + Bz + SB + GlcNH2-MRP), Xyl-
MRP (MSG + Bz + SB + Xyl-MRP), and MSG + Bz + SB + Xyl-MRP + IMP)
maintained at 23  C (Table 1). (B) Shows the normalized mean   standard
error of the mean tonic CTresponse from 3 animals for MSG + SB + Bz, MSG +
SB + Bz + IMP, MSG + SB + Bz + Xyl-MRP, and MSG + SB + Bz + IMP + Xyl-MRP.
***P < 0.001 relative to MSG + SB + Bz. Figure 7 Effect of MRPs on human salt taste perception using constant
stimuli method. (A) The effect of MRPs was assessed on salt taste using the
constant stimuli method and the median effective salt concentration scale in
0.08 M NaCl. This experiment was performed with the MRPs concentrations
at 0.0025%, 0.005%, 0.01%, 0.025%, and 0.1% in 0.08 M NaCl. (B) The
effect of 0.01% GalA-MRP was assessed on salt taste using the constant
stimuli method and the median effective salt concentration scale in 0.08 M
NaCl (pH 6.4) maintained at 30  C and 45  C. (C) The effect of 0.01% GalA-
MRP was assessed on salt taste using the constant stimuli method and the
median effective salt concentration scale in 0.08 M NaCl (pH 6.4) in the
absence and presence of 4% ethanol (ETH). In each case, 5 equidistant
concentrations of NaCl ranging from 0.078 to 0.086 M (for the enhancing
effect) and 0.074 to 0.082 M (for suppressing effect) were used (Table 2). All
samples were evaluated by 10–14 trained panelists.
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MRPs that produce an increase in the Bz-insensitive
NaCl CT response in both rat and mouse models. This
may be due to the fact that the human amiloride- and
Bz-insensitive salt taste receptor is more sensitive to MRPs
than in the rat.
Consistent with the CT studies, in humans, the salt taste
intensityincreasedwithincreasingthetemperatureofthetest
solution from 30  Ct o4 5 C (Figure 7B). In addition, the
increase in the salt intensity in the presence of GalA-MRP
was also enhanced at 45  C relative to 30  C. Thus, the
changes in human salt taste intensity mimic the effect of tem-
perature on the Bz-insensitive NaCl CT response.
In humans, in mixtures containing 0.08 M NaCl + 4% eth-
anol, the salt intensity was greater relative to NaCl alone
(Figure 7C). This suggests that ethanol, a modulator of
TRPV1t, also enhances salt taste in humans. In mixtures
containing 0.01% GalA-MRP + 4% ethanol, the perceived
salt intensity was greater than that of 4% ethanol alone.
However, the perceived salt taste intensity was less than that
of GalA-MRP alone.
Human sensory evaluation was also performed using a
model soup containing MRPs conjugated with GalA,GlcNH2,
and Xyl using a quantitative descriptive analysis and a
7-point intensity scale. Between 0.00001% and 0.00005%
GalA-MRP (Figure 8A; blue bar) increased and above
0.0001% suppressed the salt taste. At 0.00005%, the relative
salt intensity was signiﬁcantly (P < 0.001) enhanced relative
to control solution by 19%. At 0.0002%, GlcNH2-MRP
(Figure 8A; red bar) signiﬁcantly (P < 0.05) enhanced
the relative salt intensity relative to control solution by
10%. In contrast, Xyl-MRP did not show an increase in
the relative salt intensity; however, at 0.02% (Figure 8A;
green bar) it showed a signiﬁcant (P < 0.05) salt-masking
activity relative to control solution by 24%.
In order to conﬁrm that GalA-MRP also modulates the
amiloride-insensitive salt taste in humans, additional experi-
ments were conducted using 0.15 M NaCl solutions contain-
ing amiloride. As shown in Figure 8B, GalA-MRP produced
a biphasic effect on salt taste in the presence of amiloride.
However, in the presence of NaCl + amiloride, GalA-MRP
produced a maximum increase in the perceived salt taste
intensity at 0.005%.
Discussion
The results presented in this paper suggest that a relationship
exists between the modulation of human salt taste by MRPs
and their effects on the Bz-insensitive NaCl CT responses in
rat and mouse models. This relationship is derived from mix-
ture interactions between NaCl and MRPs, vanilloids, tem-
perature, pH, amiloride, Bz, and SB observed in CT taste
nerve recordings in rats and mice and in human sensory eval-
uation of salt taste. Below, we will discuss the proposed un-
derlying physiological basis of this relationship.
MRPs as salt taste modiﬁers
In human sensory evaluation, MRPs were reported to have
no taste of their own. This is consistent with the observations
that in the absence of mineral salts, MRPs failed to elicit
a CT response above baseline (Figure 1A), and thus, by
themselves, MRPs are not gustatory stimuli. MRPs are non-
pungent. In contrast to MRPs, some of the modulators of
TRPV1t are not only gustatory stimuli by themselves but
theyalsoproduceadditionalpharmacologicalandpsychoac-
tiveeffects.Thisseriouslylimitstheiruseaspossiblesalttaste
modiﬁers. At low concentrations, humans report the taste of
Figure 8 Effect of MRPs on human salt taste perception using quantitative
descriptive analysis. (A) Effect of MRPs was assessed on salt taste using
a quantitative descriptive analysis method and a 7-point intensity scale in
a 0.3% model vegetable soup (Table 2). The soup without MRPs was
presented as a control and given an intensity of 4 on a 7-point intensity
scale. MRPs were added to the soup at 0.00001%, 0.00002%, 0.00005%,
0.0001%, 0.0002%, 0.001%, 0.005%, and 0.02%. The ﬁnal salinity of
the test solution was adjusted to 0.1 M NaCl. All samples were evaluated
by 5–17 trained panelists. Values are presented as mean   standard error of
the mean (SEM) of relative salt intensity. *P < 0.025 and **P < 0.005
(Bonferroni adjusted). (B) Effect of GalA-MRP on salt taste using a
quantitative descriptive analysis method and a 7-point intensity scale in
a 0.15 M NaCl solution containing 50 · 10
 6 M amiloride. Values are
presented as mean   SEM of relative salt intensity from 7 trained panelists.
**P < 0.005; ***P < 0.001 (Bonferroni adjusted).
Relationship Between Human Salt Taste and TRPV1t 675alcohol as sweet and at high concentrations it tastes bitter.
Humans report the taste of nicotine as bitter. Both alcohol
and nicotine also produce pharmacological and psychoac-
tive effects.Moreover, alcohol andnicotine areonly effective
as TRPV1t modiﬁers at relatively high concentrations.
Although the vanilloids (RTX and CAP) are the most potent
agonists of TRPV1t (Lyall et al. 2004, 2005c), they are
extremely pungent and thus have a strong trigeminal com-
ponent. Thus, MRPs offer a distinct advantage over most
of the above TRPV1t agonists as possible salt taste modi-
ﬁers. In humans, MRPs modulate salt at relatively low con-
centrations (Figures 7 and 8) without affecting other taste
qualities and are not associated with additional complica-
tions involving trigeminal, pharmacological, and psychoac-
tive effects.
Biphasic effects of MRPs on human salt taste and the
Bz-insensitive NaCl CT responses in rodents
All modulators of TRPV1t tested so far (RTX, CAP, ethanol,
nicotine, temperature, cetylpyridinium chloride, N-geranyl
cyclopropylcarboximide, and naturally occurring Maillard
peptides)producedbiphasiceffectsontheBz-insensitiveNaCl
CT responses in both rats and mice (Lyall et al. 2004, 2005a,
2005b, 2005c, 2007; Dewis et al. 2006; Rhyu et al. 2006).
Consistent with these studies, all MRPs conjugated with dif-
ferent sugar moieties also produced biphasic effects on the
Bz-insensitive NaCl CT responses (Figures 1,4 and 5). The
dose-response proﬁles of MRPs were strongly dependent
upon the conjugated sugar moiety. Among the sugars tested,
MRPs conjugated with GlcNH2 and GalA were most effec-
tive and gave a maximum increase in the Bz-insensitive NaCl
CT response by almost 100% relative to N + Bz at 0.25%
(Table 3). The results suggest that the binding of MRPs
to the activating site on TRPV1t is determined by the con-
jugated sugar moiety.
In comparison to RTX (0.0000063%) and CAP (0.0012%)
(Lyall et al. 2004, 2005c), GalA-MRP and GluNH2-MRP
produced maximum increase in the CT response at 0.25%.
However, the increase in the maximum CT response was
equivalent to that seen with RTX and CAP. At the highest
concentration of GlcNH2-MRP and GalA-MRP (1%), the
CT response was inhibited by 35% and 45%, respectively.
In contrast, RTX (0.00063%) and CAP (0.006%) inhibited
the CT response by 100% to the baseline, respectively. Thus,
in comparison to RTX and CAP, MRPs are far less potent
modulators of TRPV1t. In contrast, MRPs conjugated with
Xyl, Fru, and Glc are about 2, 3, and 4 fold less potent than
GlcNH2-MRP and GalA-MRP, respectively.
The Bz-insensitive NaCl CT response isobserved in the ab-
sence of TRPV1t agonists and when stimulating solutions
are presented at room temperature (Figures 1–5). This sug-
gests that TRPV1t is constitutively active at room tempera-
ture and its activity is further enhanced in the presence of
TRPV1t modulators. This is a major difference between
TRPV1t and the pain receptor TRPV1. The native TRPV1
channel in dorsal root ganglia or the cloned TRPV1 ex-
pressed in human embryonic kidney (HEK-293) cell line is
not constitutively active (Caterina et al. 1997, 2000). TRPV1
is opened in the presence of low pH, vanilloids, or elevated
temperature. However, recent reports suggest that TRPV1 is
also tonically activated in vivo abdominal viscera and is in-
volved in body temperature regulation (Gavva et al. 2007;
Steiner et al. 2007). In mesenteric resistance arteries and
the renal cortex and medulla, tonically active TRPV1 is in-
volved in blood pressure regulation (Wang Y and Wang DH
2006;Wangetal.2007).Recently,additionalrolesofTRPV1
receptorsoritsvariantshavebeenproposedintheofftasteof
artiﬁcial sweeteners and metallic taste of Cu
2+,Z n
2+, and
Fe
2+ (Riera et al. 2007) and in the sensitization of changes
in osmolarity to CAP in trigeminal sensory neurons (Liu
et al. 2007).
It is important to note that in human psychophysical stud-
ies (Figures 7 and 8), MRPs conjugated with GalA, GlcNH2,
Xyl, or Fru produced a biphasic effect on salt taste. Consis-
tent with the CT data, the potency of the MRPs was related
to the conjugated sugar moiety and the order of potency was
the same as seen in the CT experiments (GalA = GlcNH2 >
Xyl > Fru > Glc). A signiﬁcant difference between the CT
data and the human psychophysical data was in the concen-
tration range at which MRPs modulate the human salt re-
sponses. The GalA-MRP and GlcNH2-MRP produced
their maximum increase in salt perception using quantitative
descriptive analysis at 0.0005% and 0.002%, respectively. In
comparison, using the magnitude scale GalA-MRP pro-
duced its maximum increase in salt perception at 0.01%.
These differences in the concentration of MRPs between
the 2 methods may arise because of the use of 0.1 M NaCl
dissolved in the model soup in the quantitative descriptive
analysis and the use of 0.08 M NaCl solution in the analysis
using the magnitude scale method. These results suggest that
the presence of additional TRPV1t modulators and/or en-
dogenous naturallyoccurring Maillard peptides inthe model
soup shift the dose-response curve to the left on the MRP
concentration axis. GalA-MRP also produced a biphasic ef-
fect on human salt taste in the presence of amiloride (Figure
8B) providing additional support for the hypothesis that
GalA-MRP also modulates an amiloride-insensitive salt
taste receptor in humans.
Inhumansensorystudies,theincreaseinsalttasteintensity
occurred over a very narrow concentration range of MRPs
and become antagonists at higher concentrations. This may
have been a limiting factor in the discovery of effective hu-
man salt taste enhancers. Depending upon where an individ-
ual may fall on the MRP dose–response curve, a particular
concentration of MRP may act as an agonist, produce no
change or act as an antagonist of the salt response, thus pro-
ducing inconsistent effects on salt perception.
MRPs produced only acute effects on TRPV1t that were
completely reversible (Figure 1B). Stimulating the tongue
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producible changes in the CT responses, suggesting that
TRPV1t channel does not desensitize with repeated stimula-
tions with MRPs. In our previous studies, no channel desen-
sitization was observed by repeated application of RTX
(<1 · 10
–6 M), CAP (<40 · 10
–6 M), ethanol (<40%), nico-
tine (<10 · 10
–3 M), and elevated temperature (<42  C)
(Lyall et al. 2005a, 2005b, 2005c, 2007). In contrast, pro-
longed or repeated activation of TRPV1 induces desensitiza-
tion and insensitivity of the receptor to subsequent stimuli
(Caterina et al. 1997, 2000). However, at high concentra-
tions, the above modulators decrease the magnitude of the
Bz-insensitive NaCl CT response from its maximum value
(Lyall et al. 2005a, 2005b, 2005c, 2007). Our preliminary
studiessuggestthatdesensitizationofthechannelinthepres-
ence of TRPV1t modulators is related to changes in intracel-
lular Ca
2+ ([Ca
2+]i) of taste receptor cells (Heck et al. 2005).
An increase in taste receptor cell [Ca
2+]i reduced the response
magnitude in the agonist dose-response curve at all agonist
concentrations, and a decrease in [Ca
2+]i increased the re-
sponse magnitude in the agonist dose-response curve at all
agonist concentrations and signiﬁcantly inhibited the decline
from maximal response at the higher agonist concentrations
seen under control conditions (Heck et al. 2005). It is likely
that Na
+ entry through TRPV1t depolarizes taste receptor
cells resulting in an increase in [Ca
2+]i via the voltage-gated
Ca
2+ channels in taste receptor cells or the release of Ca
2+
from intracellular stores (Lyall et al. 2007). This suggests
that preventing the desensitization of TRPV1t at higher
MRP concentrations would be beneﬁcial in extending the
concentration range over which MRPs can act as salt taste
enhancers. In addition, the maximum activation of the
TRPV1t will be maintained over a wider range of MRP con-
centrations. This means that MRPs can act as salt taste
enhancers in a much larger human population displaying
different afﬁnities of MRPs for TRPV1t.
Interaction of MRPs and other TRPV1t modulators on the
salt responses
In the absence of a TRPV1t agonist, the Bz-insensitive NaCl
CT response is not affected by changes in external pH (Lyall
et al. 2002). Also, in the absence of a TRPV1t agonist, the
temperature threshold of the Bz-insensitive NaCl CT re-
sponse is independent of changes in external pH (Lyall
et al. 2004, 2005c). This indicates that the constitutive
TRPV1t activity is not modulated by external pH. This is
a signiﬁcant difference between the cloned pain receptor,
TRPV1, and the amiloride- and Bz-insensitive salt taste
receptor, TRPV1t. TRPV1 is not constitutively active. A
decrease in external pH is one of several stimuli that can
open the channel (Davis et al. 2002; Gunthorpe et al.
2002; Geppetti and Trevisani 2004). However, the Bz-
insensitive NaCl CT responses in the presence of TRPV1t
agonists are strongly dependent upon external pH. In the
presence of TRPV1t agonists, a change in external pH from
6 to either 4.7 or 9.7 increased the temperature threshold of
the Bz-insensitive NaCl CT responses (Lyall et al. 2004,
2005a, 2005b, 2005c, 2007). In our studies, the CT response
to N + Bz + GalA-MRP gave the maximal response between
pH 6 and 7 (Figure 3A). At constant external pH, changes in
intracellular pH do not affect salt responses in the presence
ofRTX (Lyalletal.2004,2005c).ThissuggeststhatH
+bind-
ing to an external site on the TRPV1t channel protein mod-
ulates the afﬁnity of TRPV1t agonists, including that of
MRPs, to their respective intracellular binding sites on the
channel protein.
An important property of TRPV1t is that it can integrate
the effect of multiple stimuli to produce additive effects on
the Bz-insensitive NaCl CT responses (Lyall et al. 2004,
2005a, 2005b, 2005c, 2007). Consistent with this, in the pres-
ence of GalA-MRP, the effect of temperature and the pep-
tide were additive (Figure 3B). GalA-MRP enhanced the
Bz-insensitive NaCl CT response without a shift in the tem-
perature threshold of the CT response. Consistent with this,
ethanol and nicotine also increased the Bz-insensitive NaCl
CT response without a shift in the temperature threshold of
the CT response (Lyall et al. 2005a, 2005b, 2007). In contrast
to ethanol, nicotine, and GalA-MRP, RTX shifted the tem-
peraturethresholdoftheBz-insensitiveNaClCTresponse to
lower temperatures (Lyall et al. 2004, 2005c). This suggests
that the mechanism by which vanilloids (RTX and CAP) ac-
tivate the channel is different from that of ethanol, nicotine,
and MRPs.
The results shown in Figure 7B suggest that elevated tem-
perature and GalA-MRP produce additive effects on human
salt taste. In rats, increasing the temperature from 30  Ct o
43  C inhibited the Bz-sensitive NaCl CT responses from its
maximum value to baseline in a dose-dependent manner
(DeSimone and Lyall 2008). This suggests that at 43  C
the contribution of epithelial Na
+ channel to salt taste is neg-
ligible. Thus, at 45  Cboth the GalA-MRP–induced increase
in the Bz-insensitive NaCl CT response andthe GalA-MRP–
induced increase in the salt taste perception in humans are
most likely due to the amiloride- and Bz-insensitive salt taste
receptorandnotduetotheamiloride-sensitiveepithelialNa
+
channels. This is further supported by the observations that
GalA-MRP produced increase in human sensory salt taste
evaluation in the presence of amiloride (Figure 8B).
The increase in the Bz-insensitive NaCl CT response by
GalA-MRPandethanolwereadditive(Figure 3D),suggesting
that ethanol and GalA-MRP bind to different intracellular-
binding sites on the TRPV1t receptor. In human psychophys-
ical studies, in mixtures containing ethanol and GalA-MRP,
the salt intensity was slightly higher than ethanol alone
but was less than that of GalA-MRP (Figure 7C). This
suggests that ethanol produces mixture interactions with
GalA-MRP resulting in a decrease in the salt perception.
This further suggests that the relationship between human
salt perception and ethanol is shifted to the left on the
Relationship Between Human Salt Taste and TRPV1t 677MRP concentration axis relative to that of rat (Lyall et al.
2005c).
In contrast to ethanol, in mixtures containing a subthresh-
old concentration of RTX or CAP plus GalA-MRP, GalA-
MRP enhanced the Bz-insensitive NaCl CT response.
In each case, the GalA-MRP + RTX or GalA–MRP + CAP
induced increase in the CT responses was greater than the
increase in the CT response in the presence of RTX alone,
CAP alone, or GalA-MRP alone. These results suggest that
the binding of RTX or CAP to an intracellular-binding site
on the TRPV1t alters the conformation of the channel
and sensitizes the channel to further stimulation by GalA-
MRP. These results are in agreement with previous studies
(Lyall et al. 2004, 2005a, 2005b, 2005c, 2007) in which a
subthreshold concentration of RTX shifted the tempera-
ture threshold of the Bz-insensitive NaCl CT response to
the left on the agonist concentration axis in the presence
of ethanol or nicotine. These results support the notion
that at subthreshold concentrations, vanilloids (RTX and
CAP) produce allosteric effects on the Bz-insensitive NaCl
CT response in the presence of ethanol, nicotine, and
GalA-MRP.
MRPs produce their effects by interacting with TRPV1t
The speciﬁcity of MRPs as modulators of TRPV1t is sup-
ported by the observations that SB inhibits the effects of
MRPs on the Bz-insensitive NaCl CT response (Figures 2
and 5). The constitutive TRPV1t activity is inhibited to base-
line in the presence of SB and no further increase in the Bz-
insensitive NaCl CT response above baseline is observed
when stimulated with RTX, CAP, ethanol, nicotine, and el-
evated temperature (Lyall et al. 2004, 2005a, 2005b, 2005c,
2007) or GalA-MRP (Figures 2 and 5). At an external pH of
6.4, RTX, CAP, ethanol, nicotine (Lyall et al. 2004, 2005a,
2005b, 2005c, 2007), and GalA-MRP (Figure 2) have no ef-
fect on the Bz-sensitive NaCl CT response. In addition, SB
does not block ENaC (Figure 2C). The additional proof
that GalA-MRP interacts with TRPV1t is provided by the
observation that TRPV1 knockout mice, that lack the Bz-
insensitive component of the NaCl CT response, also do
not respond to Gal-MRP (Figure 5B–D), ethanol, RTX, nic-
otine, and elevated temperatures (Lyall et al. 2005a, 2005c,
2007). Taken together, the data support the conclusion that
MRPsproducetheireffectonsaltresponsesviatheamiloride-
and Bz-insensitiveTRPV1t cationchannels infungiform taste
receptor cells. However, the exact mechanism of how MRPs
modulate the TRPV1t cation channel in taste receptor cells
remains to be established.
MRPs as umami taste modiﬁers
Similar to other MRPs, Xyl-MRP also produced effects on
salt responses between 0.1% and 1%. However, at 2.5%, it
demonstrated a signiﬁcant increase in the CT response to
MSG. Similarly, another TRPV1t modulator, N-geranyl cy-
clopropylcarboximide, at higher concentrations enhanced
the CT response to MSG and increased umami taste in hu-
mans (Dewis et al. 2006). It is important to point out that in
our studies, CT responses to MSG were monitored in the
presence of Bz + SB. This eliminates the contribution of
Na
+ to the MSG CT response and elicits a response only
to glutamate. In the past, studies have only used amiloride
to block epithelial Na
+ channels while measuring the CT or
glossopharyngeal taste nerve responses to MSG (Damak
et al. 2003; Zhao et al. 2003). Our studies further suggest that
another ideal way to measure CT responses to MSG is to use
TRPV1 knockout mice and to record CT nerve responses in
the presence of amiloride or Bz. Our results suggest that at
high concentrations, Xyl-MRP and N-geranyl cyclopropyl-
carboximide interact with umami taste receptor (T1R1 +
T1R3) and modulate umami taste in humans. In contrast
to the wild-type mice, in T1R3 knockout mice, IMP did
not potentiate the CT response to MSG (Damak et al.
2003). This suggests that IMP targets T1R3 to potentiate
the CT response to MSG. It is likely that Xyl-MRP and
IMP produce their effects on the CT response to MSG by
acting on the T1R3 part of the umami taste receptor
(T1R1 + T1R3). The observation that in the presence of
IMP + Xyl-MRP the CT response to MSG is less than ad-
ditive relative to IMP alone or Xyl-MRP alone (Figure 7),
suggests that they compete for the same binding site on
T1R3 (Damak et al. 2003). Xyl-MRP is a salt taste modiﬁer
at low concentrations and an umami taste modiﬁer at high
concentrations inbothhumansandanimalmodels.Thissug-
gests that it acts on similar umami (Li et al. 2002; Damak
et al. 2003) and amiloride-insensitive salt taste receptors in
humans, rats, and mice.
Insummary,ourstudiesshowthatinthepresence ofNaCl,
MRPs increase the Bz-insensitive NaCl CT response. Below
0.25%, GlcNH2-MRP and GalA-MRP enhanced and above
0.25% inhibited CT responses to 0.1 M NaCl. GalA-MRP
produced maximum increase in the CT response between
pH6and7.Stimulatingthetonguewithsolutions containing
RTX, CAP, ethanol, and elevated temperature increased the
sensitivity of the CT response to GalA-MRP. Because the
effects of GalA-MRP on NaCl are blocked by SB and
because TRPV1 knockout mice are insensitive to GalA-
MRP, ethanol, RTX, and temperature, we conclude that
MRPs produce effects on salt taste by a direct action on
the Bz-insensitive TRPV1t salt taste receptor. Thus, among
the MRPs studied, GlcNH2-MRP and GalA-MRP satisfy
most of the properties necessary for them to qualify as salt
taste modiﬁers, namely that they are tasteless, odorless, non-
pungent, stable at elevated temperatures, effective at rela-
tively low concentrations, produce only acute effects on
salttastethatarecompletelyreversible,andproduceadditive
effects with other TRPV1t modulators. At concentration ‡
2.5%, Xyl-MRP increases CT responses to MSG andMSG +
IMP and umami taste in humans.
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